LOS ANGELES--(BUSINESS WIRE)--CytRx Corporation’s (NASDAQ:CYTR) majority-owned subsidiary, RXi Pharmaceuticals Corporation (RXi), today announced that RXi President and CEO, Tod Woolf, Ph.D., and RXi co-founder, Scientific Advisory Board Chairman and Nobel Laureate, Craig Mello, Ph.D., will be featured at IBC’s 12th Annual Drug Discovery & Development of Innovative Therapeutics (DDT) World Congress in Boston on August 6-9, 2007.
Dr. Mello will deliver a keynote address on RNAi on Wednesday, August 8 at 11:45 a.m. Eastern time. Dr. Mello was awarded the 2006 Nobel Prize in Medicine for his co-discovery of RNAi.
